IDH1 and central nervous system cancer: First, we investigated the relationship between PACSIN1 and clinical indicators of gliomas (grades, IDH1 mutation status, 1p/19q codeletion status and different molecular subtypes defined by TCGA network (Verhaak et al., 2010)).